Tatva Chintan, a company in the Specialty Chemicals industry, reported revenue of ₹217 crore and net profit of ₹21 crore for the September 2026 quarter.
Tatva Chintan (NSE: TATVA) closed at ₹1,601.80 on 20 Nov 2026, up 4.5% over the past year. Its market capitalisation is ₹3,747 crore and it trades at 58.6 times earnings.
Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.